John-Hanson Machado

6PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)NeurogeneticsCancer geneticsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 13, 2026
Preclinical and clinical efficacy of the HDAC6 inhibitor ricolinostat in combination with BCR pathway inhibitors in relapsed/refractory chronic lymphocytic leukemia.

|Jul 28, 2025
Rare germline variant in NFATC4 associated with familial CLL.

Gilad Itchaki, Harrison Bai, Grace Tiao

|May 05, 2023
Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples.

Jasneet Kaur Khalsa, Justin Cha, Filippo Utro

|Feb 02, 2023
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors.

Deepti Gadi, Stephen P Martindale, Pui Yan Chiu

|Oct 31, 2022
Rare Germline ATM Variants Influence the Development of Chronic Lymphocytic Leukemia.

Benjamin L Lampson, Aditi Gupta, Svitlana Tyekucheva

|Nov 07, 2021
A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia.

Deepti Gadi, Alec Griffith, Svitlana Tyekucheva

Pageof 1

Frequent Collaborators

6 joint publications

Jennifer R Brown

3 joint publications

Svitlana Tyekucheva

2 joint publications

Emily Thrash

2 joint publications

Philippe Armand